Multicenter randomized controlled trial of Vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: The Valkyrie study - Vriese AS, de; Caluwé, R; Pyfferoen, L (J Am Soc Nephrol, 2020)